Latest

NorthStar and QSA Global sign multi-year partnership to secure actinium-225 supply chain

NorthStar Medical Radioisotopes and QSA Global have announced a new strategic services agreement to support commercial-scale production of actinium-225 through a closed-loop radium-226 target supply and recycling programme for targeted alpha therapies

Find out more

You need to be a subscriber to read this article.
Click here to find out more.

Why most organisations are failing AI and ISO 42001 audits — and how to...

Eight in ten executives admit their company wouldn't pass an AI governance audit. With the EU AI Act arriving this...
See more

ProBioGen debuts next-gen AGE1.CR.ReX avian designer cell line

ProBioGen has launched its new avian designer cell line for stable, high-titer poxvirus production, which has already been used — alongside the company's proprietary TetherexX System — in a recent initiative towards an African Bundibugyo Ebola virus vaccine

Emalex Biosciences announces positive Phase III results for ecopipam in Tourette syndrome

The clinical trial showed ecopipam could cut the risk of relapse in half for children with Tourette's, without the severe side effects that plague current FDA-approved therapies

CSL's Seqirus discontinues production of Benpen amid generic competition

The company cited competition from generics as its reason behind the discontinuation, with the TGA saying that supply of the injection will continue until existing stock is gone

Vetter named Best Managed Company for seventh year in a row

The CDMO was the only company to be awarded Platinum status, having been recognised for its strategic focus, economic success and sustainability targets

Tecan establishes direct sales and service operations in India with new Gurugram-based team

Tecan has launched direct operations in India, incorporating Tecan India on 1 April 2026 and establishing a dedicated sales and service team in Gurugram, as the company strengthens its presence in the pharma, biotech and diagnostics sectors of one of its fastest-growing markets

Oncopeptides signs Central and Eastern European distribution deal with Salus for Pepaxti

Oncopeptides has entered an exclusive distribution and commercialisation agreement with Salus Group covering 11 Central and Eastern European markets for its multiple myeloma drug Pepaxti, accelerating the regional launch ahead of the company's original timeline

Eli Lilly to expand into infectious disease with $4bn triple vaccine acquisition

The pharma giant has reportedly agreed to acquire Curevo, LimmaTech Biologics and Vaccine Co in a strategic push beyond its blockbuster obesity franchise

From lab to launch: transforming pharmaceutical formulation development with GEA’s CFC Lab Coater

A new generation of continuous film coating technology is giving R&D teams the speed, precision and scalability they need to take products from the laboratory to commercial production without the traditional bottlenecks

More stories

Analysis

Conjugation chemistry key to unlocking next-generation oligonucleotide therapies, says Bachem

As demand for oligonucleotide therapeutics accelerates, Bachem's Director of Oligonucleotide Production explains how conjugation chemistry is helping CDMOs overcome delivery challenges
Manufacturing

FUJIFILM Cellular Dynamics opens new iPSC manufacturing facility in US

The new site will serve as the company's headquarters and will increase Fujifilm's capacity for induced pluripotent stem cell development and manufacturing, as demand increases with new approach methods in research
You need to be a subscriber to read this article.
Click here to find out more.
Sustainability

PFAS regulation pressure intensifies as new Chemspec whitepaper urges early industry action

A new whitepaper launched at Chemspec Europe 2026 warns that tightening global PFAS regulation could trigger major supply chain and compliance challenges for chemical manufacturers unless companies begin transition planning now
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Rice-ing to the occasion: how plant-based excipients are gaining ground in pharmaceutical manufacturing

As clean-label expectations migrate from health foods into pharmaceutical supply chains, natural ingredient supplier RIBUS says that rice-based excipients are becoming a credible alternative to synthetic standards
You need to be a subscriber to read this article.
Click here to find out more.
Drug Delivery

No more needles? How intradermal delivery could transform vaccine access

A new review has put forward novel needle-free Intradermal (ID) delivery formats as an effective alternative to traditional administration using needles, with the technologies demonstrating improved immunisation coverage and cost savings
Research & Development

Biogen and Denali discontinue Parkinson’s candidate BIIB122 after Phase IIb LUMA study miss

Biogen and Denali Therapeutics have halted development of BIIB122 for Parkinson’s disease after the Phase IIb LUMA trial failed to slow disease progression, despite achieving strong biomarker activity and an acceptable safety profile
Regulatory

MHRA approves beremagene geperpavec gene therapy gel for DEB from birth

The MHRA has approved beremagene geperpavec (Vyjuvek), a topical gene therapy gel for wounds in patients with dystrophic epidermolysis bullosa (DEB), for use from birth onwards
Finance

Bora Group to acquire MacroGenics’ manufacturing operations and CDMO business

The purchase will hand the Group a biologics drug substance manufacturing facility and a warehousing centre in Maryland, which Bora plans to use in cooperation with Tanvex Biopharma to scale its end-to-end biologics platform
Manufacturing

etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage

etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
You need to be a subscriber to read this article.
Click here to find out more.
Analysis

Purification: a critical success factor in peptide programmes

This article examines why advanced chromatography, process intensification and sustainability initiatives can help manufacturers to improve process efficiency and long-term supply security
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Pharma supply chains face record drug shortages as geopolitical, cyber and quality risks converge

A new Moody's report identifies four compounding risk factors driving pharmaceutical supply chain instability and warns that siloed risk management is leaving the sector dangerously exposed

Sponsor content

Reducing fluid control and automation complexity in pharma process development

Aligning mechanical, electrical, instrumentation, and automation engineering through compatible technologies can reduce development risks and accelerate pharmaceutical...

Almac group delivers record year of growth

Revenue rises to £1.1 billion as profit increases 16% and workforce expands to more than 7,900 amid continued global investment programme

From ozone protection to climate action: the global transition away from CFCs and HFAs background

In the early 1990s, the world faced a stark environmental warning: the ozone layer, Earth’s natural shield against harmful ultraviolet radiation, was thinning at...

FDA inspections and Form 483 responses: What companies need to know

NSF experts explain how companies can strengthen Form 483 responses, improve CAPA planning and reduce regulatory risk following FDA inspections

NSF announces fourth annual Pharma Biotech Conference 2026

Industry leaders to explore how pharma and biotech companies can build resilient quality systems beyond compliance

Compact, economical and sustainable cooling solutions for laboratories

Huber Unichillers offer space-saving and environmentally friendly temperature control for research and industrial applications

Pioneering AAV approach unlocks cause of rheumatoid arthritis pain

Karolinska Institute researchers use AAV products to uncover neural mechanisms behind rheumatoid arthritis pain

Leading European CDMO Aenova expands automated semi-solids tube packaging capacity

New state-of-the-art high-speed line boosts annual capacity to over 50 million tubes per year and enhances flexibility for pharmaceutical creams, gels and ointments

AnalytiChem launches US webshop for prepared culture media products and sterile dyes

Redipor microbiological media product range now available to order online in the USA for the first time

Lonza and Oxford Nanopore launch direct RNA sequencing solution for GMP mRNA quality control

New nanopore sequencing and machine learning workflow simplifies multi-attribute QC testing for mRNA therapeutics

Titan Enterprises strengthens operational performance through streamlined processes, innovation and supply chain resilience

Liquid flow meter specialist Titan Enterprises has strengthened its organisational performance through targeted process streamlining, operational efficiencies and...

Free workshop – Measuring and characterising polymers workshop

Anton Paar UK announces 2026 Polymer Processing and Characterisation Workshop in Luton

Featured companies

Bürkert Fluid Control Systems, also known simply as Bürkert, is renowned for its expertise in the design and manufacturing of fluid control systems and components. Since 1974, Butterworth Laboratories has provided independent, contract analytical chemistry services to the global pharmaceutical and related industries. Consequently, we are... Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party... Labtex is a specialist laboratory and process chemistry equipment solutions provider. A dynamic team of professionals with expertise in research and process development across...
See more

Resource Centre

Latest Media See all

From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND

From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND

Manufacturing Chemist Stand Side with GEA and Hovione

Manufacturing Chemist Stand Side with GEA and Hovione

Manufacturing Chemist Stand Side with Piramal Pharma Solutions

Manufacturing Chemist Stand Side with Piramal Pharma Solutions

Manufacturing Chemist Stand Side with Almac Group

Manufacturing Chemist Stand Side with Almac Group

Latest Reports See all

Panthera joins the Association of Multisite Research Corporations (AMRC)

Membership strengthens Panthera’s ability to collaborate across the industry, contribute to collective advocacy and help shape the future of clinical research

Terminal sterilisation versus aseptic filling: ensuring drug product safety

The sterility of drug products is critical to patient safety. Choosing between terminal sterilisation or aseptic processing to achieve this should reflect the final product’s...

US mRNA policy shift: are vaccine headwinds accelerating oncology focus?

With Washington’s stance on mRNA vaccines cooling, Manufacturing Chemist examines whether policy and funding signals could influence the pharmaceutical industry’s most...

Reimagining biosimilars: faster access, stronger supply, sustainable healthcare

Outdated development models, uneven adoption and policy barriers are holding Europe back. Dr Kevin Robinson (KSR) spoke to Matt Erick (ME), Head of Advanced Markets at Biocon...

Company News

IMCD appoints Behnosh Yaghobi as Managing Director Middle East Industry leader to drive the next phase of regional growth
Hovione announces leadership transition and interim Co-CEO structure Co-CEOs for the transition period, António Almeida and Dr. Marco Gil, bring combined 40 years of experience with Hovione to their new role
CellProthera appoints new board members for late-stage clinical development CellProthera, a clinical-stage biotechnology company developing regenerative cell therapies for ischemic diseases, today announced the appointment of Jérôme Hirtzlin and Anne...
AES Cleanroom Technology appoints John Groth as Chief Revenue Officer AES Cleanroom Technology, a leading provider of modular cleanroom design, manufacturing, and construction solutions for the life sciences and biopharmaceutical industries, has...
Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth ProBioGen announced the appointment of Dr. Simon Johannes Bulling, PhD, as Chief Operating Officer (COO), effective April 15, 2026
New leadership at DWK Life Sciences: Michael Werth succeeds Armin Reiche After serving as CEO for 25 years, Armin Reiche hands operational responsibility to Michael Werth and joins the Advisory Board
MasterControl appoints David Edwards as CEO to drive next phase of growth Former CEO Jon Beckstrand Appointed Chairman of the Board; Prior Chair and Salt Lake City Business Pioneer Richard Beckstrand Transitions to Board Member
Quibim appoints Itta MacNevin as Chief Business Officer to accelerate global growth and life sciences partnerships Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased to announce the appointment of Itta MacNevin as Chief Business Officer (CBO). The...
See more

Upcoming events See all

CPhI North America

2–4 June 2026 | Exhibition | Pennsylvania, US

BIO International Convention

22–25 June 2026 | Convention | Boston, US

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy

About Manufacturing Chemist

Through digital, live and print products, Manufacturing Chemist informs and inspires business leaders and decision-makers around the world. With a digital-first strategy, the Group’s Editors write breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry from ingredients and packaging to regulation, retail and marketing.

Pharma 5.0 represents a paradigm shift in pharmaceutical manufacturing, paving the way for a future where medications are developed faster, customised to individual patient needs and delivered with uncompromising quality. It is not just about innovation; it is about transforming the way we think about healthcare and ultimately improving the lives of patients around the world.